Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03174522
Recruitment Status : Recruiting
First Posted : June 2, 2017
Last Update Posted : May 5, 2021
Sponsor:
Collaborator:
Andalusian Network for Design and Translation of Advanced Therapies
Information provided by (Responsible Party):
Ixaka Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 30, 2022
Estimated Study Completion Date : July 31, 2023